Progress and Innovative Combination Therapies in Trop-2-Targeted ADCs.

导出 OA

翻译打印收藏纠错

作者： Yizhi,Jiang ^[1] ; Haiting,Zhou ^[1] ; Junxia,Liu ^[1] ; Wentao,Ha ^[1] ; Xiaohui,Xia ^[1] ; Jiahao,Li ^[1] ; Tengfei,Chao ^[1] ; Huihua,Xiong ^[1]

作者单位： Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. ^[1]

关键词 Trop-2 antibody–drug conjugates biomarker identification combination therapy drug delivery systems extracellular vesicles personalized therapy

DOI 10.3390/ph17050652

PMID 38794221

发布时间 2024-05-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Pharmaceuticals (Basel, Switzerland)

2024年17卷5期

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Progress and Innovative Combination Therapies in Trop-2-Targeted ADCs.

Pharmaceuticals (Basel, Switzerland)

相似文献

Pharmaceuticals (Basel, Switzerland)

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Progress and Innovative Combination Therapies in Trop-2-Targeted ADCs.

Pharmaceuticals (Basel, Switzerland)

相似文献

Pharmaceuticals (Basel, Switzerland)

相关期刊

检索历史清除